Profile
ABPWW VRTX REGN VRNA ARGX ALNY
Company Name Abpro Holdings Inc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.92M $116.06B $76.56B $72.68B $53.66B $52.51B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Jin Wook Suk Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABPWW VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
ABPWW VRTX REGN VRNA ARGX ALNY
Last Close $0.0155 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $0.16 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.01 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -90.31 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 55 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABPWW VRTX REGN VRNA ARGX ALNY
1 Month Return -52.16 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -50 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -22.5 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -69 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -75.2 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -69.06 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABPWW VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Profitability
ABPWW VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM -55.19 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -824.25 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 83.19 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 93.3 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 99.59 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 96.87 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -7950.82 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -9278.92 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 0.68 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 0.06 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 10.75 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -5.22 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -5.22 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 13.12 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -7453.56 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -9278.92 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.83 34.78 18.43 -995.27 126.92 237.2
Price To Operating Cash Flows Ratio TTM -1.07 31.09 15.15 -126.33 144.96 196.51
Price Cash Flow Ratio TTM -1.07 31.09 15.15 -126.33 144.96 196.51
Income Statement (TTM)
ABPWW VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio -263.39% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -0.74 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ABPWW VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.02B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $-0.01B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ABPWW VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 28.8501
AARD Aardvark Therapeutics, Inc. Common Stock 13.88
ABCL AbCellera Biologics Inc. 3.445
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.065
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.0867
ABSI Absci Corporation 3.5599
ABUS Arbutus Biopharma Corporation 4.6254
ABVC ABVC BioPharma, Inc. 2.1
ABVX Abivax SA American Depositary Shares 111.439
ACAD ACADIA Pharmaceuticals Inc. 26.7937
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4708
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.43
ACIU AC Immune SA 3.325
ACLX Arcellx, Inc. 66.41
Unlock